Arlington Capital Management, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Arlington Capital Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$33.21 - $51.27 $369,394 - $570,276	-11,123 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$26.12 - $43.27 $34,609 - $57,332	-1,325 Reduced 10.64%	11,123 $480,000
Q1 2020 May 01, 2020	SELL	$20.56 - $63.12 $1,233 - $3,787	-60 Reduced 0.48%	12,448 $358,000
Q4 2019 Feb 10, 2020	SELL	$28.14 - $73.01 $470,050 - $1.22 Million	-16,704 Reduced 57.18%	12,508 $793,000
Q3 2019 Nov 06, 2019	BUY	$26.26 - $34.86 $767,107 - $1.02 Million	29,212 New	29,212 $823,000

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Arlington Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Arlington Capital Management, Inc. with notifications on news.